BridgeMD
New treatment option for Efficacy of Hemostatic Agents
Official title Different Hemostatic Agents Used in Partial Pulpotomy on Pulp Survival and Postoperative Pain
ClinicalTrials.gov ID: NCT07058727
What this study is testing
What is Sodium Hypochlorite 2,5%?
Sodium Hypochlorite 2,5% is an investigational medicine, being studied as a potential treatment for efficacy of hemostatic agents.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- This randomized clinical trial evaluates the efficacy of sodium hypochlorite (NaOCl), chlorhexidine (CHX), and cold saline as hemostatic agents in partial pulpotomy. The study compares postoperative pain (via VAS scores) and pulp survival (via clinical/radiographic evaluation) at 1, 3, 7 days, 6 months, and 12 months
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 15 to 55
You may be able to join if
- Permanent teeth with carious pulp exposure (no spontaneous pain).
- Positive vitality test (Endo-Ice).
- No periapical radiolucency.
You likely can't join if
- Systemic diseases affecting healing.
- Pregnancy.
- Non-vital pulp/necrosis
The study team makes the final eligibility decision.
Where it's taking place
- Adana, Sarıçam, Turkey (Türkiye)
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 15 years to 55 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Adana, Sarıçam, Turkey (Türkiye). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.